Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2014Blood Cancer JournalOpen Access

Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

AEArmin EhningerMKMichael KrämerCRChristoph Röllig

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ehninger et al. (2014) studied this question.

synapsesocial.com/papers/6a7ef7f7784326906f0fbcf3https://doi.org/10.1038/bcj.2014.39
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug2013 · 144 citations
  2. 2High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)2001 · 215 citations
  3. 3High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation2011 · 97 citations
  4. 4The L4F3 antigen is expressed by unipotent and multipotent colony- forming cells but not by their precursors1986 · 117 citations
  5. 5Anthracycline Dose Intensification in Acute Myeloid Leukemia2009 · 923 citations